Schedule 13G ownership disclosure
CLEARSIDE BIOMEDICAL INC
Common Stock, $.001 Par Value · CUSIP: 185063104
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- WHITMORE BRADFORD T
Shares: 6,523,511.00 · Class: 8.6%
- GRACE BROTHERS LP
Shares: 2,254,542.00 · Class: 2.9%
- Whitmore Holdings, LLC
Shares: 6,523,511.00 · Class: 8.6%
- Bradford Whitmore Trust
Shares: 6,523,511.00 · Class: 8.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000933430-25-000001
- Form type
- SCHEDULE 13G/A
- Filer
- Clearside Biomedical, Inc.
- CIK
- CIK 1539029
- Filed
- Mar 04, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership